Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
Malignant ascites frequently occur in patients with advanced ovarian cancer at initial diagnosis, and in almost all cases of relapse, they are closely related to poor prognosis, chemoresistance, and metastasis. To date, effective management strategies have been limited. In this study, we aimed to in...
Guardado en:
Autores principales: | Gang Shi, Pengyi Shi, Yan Yu, Jia Xu, Jinhu Ma, Yong Zhang, Zhexu Dong, Lanlin Shen, Lei Dai, Lin Cheng, Ping Cheng, Hongxin Deng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b13fbf4f68bb42d88d66d339a8f15964 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix
por: Barbara Bortot, et al.
Publicado: (2021) -
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
por: Yi Ding, et al.
Publicado: (2021) -
Antitumour activity of Annona muricata L. leaf methanol extracts against Ehrlich Ascites Carcinoma and Dalton’s Lymphoma Ascites mediated tumours in Swiss albino mice
por: Aditi Venkatesh Naik, et al.
Publicado: (2021) -
Hemorrhagic ascites endometriosis could be a cause: a case report
por: Nadia Abdelaaty Abdelkader, et al.
Publicado: (2021) -
Oncolytic Virotherapy
Publicado: (2016)